Validated QPS Assays
The vast majority of today’s modern bioanalytical methods for pharmacokinetics, pharmacodynamics, and immunogenicity assessment are based on mass spectrometry and/or immuno-bioanalytical approaches. However, for a small but important number of compounds, LC MS/MS or LBA are less than satisfactory. A good alternative is Inductively Coupled Plasma Mass Spectrometry (ICP-MS). In ICP MS, the samples are ionized by an inductively coupled plasma (ionization source) and the ions of interest are separated, detected, and quantitated by a mass spectrometer.
The QPS Assay Finder contains a broad range of validated assays for all of your bioanalytical needs.
Search For An Assay Here
Drospirenone
Matrix: | Human Serum |
Assay Range: | 0.200 - 100 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Women's Health |
Classification: | Drug Assays |
Duloxetine
Matrix: | Human Plasma |
Assay Range: | 0.5 - 200 ng/mL |
Sample Volume: | 0.25 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Analgesic |
Classification: | Drug Assays |
Dutasteride
Matrix: | Human Plasma |
Assay Range: | 0.05 - 50 ng/mL |
Sample Volume: | 0.15 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Men's Health |
Classification: | Drug Assays |
Dutasteride
Matrix: | Human Serum |
Assay Range: | 0.05 - 50 ng/mL |
Sample Volume: | 0.15 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Men's Health |
Classification: | Drug Assays |
Dutasteride
Matrix: | Human Plasma |
Assay Range: | 100 - 7500 pg/mL |
Sample Volume: | 0.3mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Men's Health |
Classification: | Drug Assays |
E-selectin
Matrix: | Human Plasma |
Assay Range: | 0.6 - 3,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
E-selectin
Matrix: | Human Serum |
Assay Range: | 0.6 - 3,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -70 |
Platform: | ELISA |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Biochemical Biomarkers |
E-Selectin (rs5361) Genotyping
Matrix: | Human Whole Blood |
Assay Range: | N.Ap. |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -80 |
Platform: | TaqMan; QuantStudio |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | N/A |
Classification: | Genomic Biomarkers |
Efavirenz (EFV)
Matrix: | Human Plasma |
Assay Range: | 1 - 1,500 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Efavirenz (EFV)
Matrix: | Human Plasma |
Assay Range: | 5 - 5,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Efavirenz (EFV)
Matrix: | Human Plasma |
Assay Range: | 15 - 6,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Empagliflozin
Matrix: | Human Plasma |
Assay Range: | 2 - 800 ng/mL |
Sample Volume: | 0.2 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC-MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Endocrinology |
Classification: | Drug Assays |
Emtricitabine (FTC)
Matrix: | Human Urine |
Assay Range: | 0.5 - 100 ug/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | N.Ap. |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Emtricitabine (FTC) Tenofovir (TFV) in presence of Lamivudine (3TC), Efavirenz (EFV), and Dolutegravir (DTG)
Matrix: | Human Plasma |
Assay Range: | 10 - 4,000 ng/mL2.5 - 1,000 ng/mL |
Sample Volume: | 0.3 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Emtricitabine (FTC)
Tenofovir (TFV)
Tenofovir (TFV)
Matrix: | Human Plasma |
Assay Range: | 5 - 3,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Antiviral - HIV |
Classification: | Drug Assays |
Enalapril
Enalaprilate
Enalaprilate
Matrix: | Human Plasma |
Assay Range: | 0.500 - 50.0 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Enoxaparin Sodium (anti-Factor IIa)
Matrix: | Human Plasma |
Assay Range: | 1.0 - 8.0 µg/mL |
Sample Volume: | 0.025 mL |
Anti-Coagulant: | Citrate |
Storage Temperature (°C): | -70 |
Platform: | Activity / Colorimetric |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Enoxaparin Sodium (anti-Factor Xa)
Matrix: | Human Plasma |
Assay Range: | 1.0 - 10.0 µg/mL |
Sample Volume: | 0.025 mL |
Anti-Coagulant: | Citrate |
Storage Temperature (°C): | -70 |
Platform: | Activity / Colorimetric |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Cardiovascular |
Classification: | Drug Assays |
Entecavir
Matrix: | Human Plasma |
Assay Range: | 50 - 20,000 pg/mL |
Sample Volume: | 0.5 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antiviral - HBV |
Classification: | Drug Assays |
Erlotinib
Matrix: | Human plasma |
Assay Range: | 5 - 2500 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-Delaware |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Erlotinib
Matrix: | Human Plasma |
Assay Range: | 7.5 - 3,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Oncology |
Classification: | Drug Assays |
Erythromycin
Matrix: | Human Plasma |
Assay Range: | 0.100 - 100 ng/mL |
Sample Volume: | 0.25 mL |
Anti-Coagulant: | Heparin |
Storage Temperature (°C): | -20 |
Platform: | LC/MS/MS |
Site: | QPS-NL |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Erythromycin
Matrix: | Human Plasma |
Assay Range: | 15 - 8,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Erythromycin
Matrix: | Human Plasma |
Assay Range: | 20 - 8,000 ng/mL |
Sample Volume: | 0.05 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | |
Therapy Area: | |
Classification: | Drug Assays |
Erythromycin A
Matrix: | Human Plasma |
Assay Range: | 6 - 3,000 ng/mL |
Sample Volume: | 0.1 mL |
Anti-Coagulant: | EDTA |
Storage Temperature (°C): | -20 & -70 |
Platform: | LC/MS/MS |
Site: | QPS-India |
CLIA: | No |
Therapy Area: | Antibiotic |
Classification: | Drug Assays |
Links to Relevant Documents
Testimonials
Thanks for the good news, I’m happy to see that within less than a month you will have developed and validated the assay. Good Job!
QPS CLIENT